Table 1 The clinical characteristic of training cohort and validation cohort
From: The diagnostic value and validation of IL-22 combined with sCD40L in tuberculosis pleural effusion
Tuberculous pleurisy (n = 50) | Malignant pleurisy (n = 32) | P value* | |
|---|---|---|---|
Training cohort | |||
Male/Female | 37/13 | 22/10 | 0.623 |
Age, median (range) | 47.6 (12.0–84.0) | 64.7 (39.0–89.0) | 0.108 |
Sputum smear or culture positive, n (%) | 11 (22.0) | -- | -- |
Validation cohort | |||
Male/Female | 34/17 | 12/13 | 0.139 |
Age, median (range) | 44.2 (14.0–87.0) | 66.5 (44.0–84.0) | 0.001 |
Sputum smear or culture positive, n (%) | 14 (27.5) | -- | -- |